BIOLASE Introduces a New Commitment to Customer Care, Quality and Innovation at Greater New York Dental Meeting 2014
29 November 2014 - 4:16AM
Business Wire
Company Hosts Numerous Special Activities
and Educational Sessions for Attendees
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers,
today announced a variety of advances and activities for the
upcoming Greater New York Dental Meeting 2014 including the
introduction of a new generation EPIC X diode laser, designed to be
the premier and complete diode laser for the whole dental team. The
Greater New York Dental Meeting, billed as the largest dental
congress and exposition in the U.S., will be held from Friday, Nov.
28-Wednesday, Dec. 3, at the Jacob K. Javits Convention Center in
New York City. The Exhibits at the meeting will be open from
Sunday, Nov. 30-Wednesday Dec. 3.
In addition, Samuel Low, DDS, the Chairman of the Company’s new
Dental Professional Advisory Board, will provide a training session
on the EPIC X (diode) and on the flagship WaterLase® iPlus
(All-Tissue) lasers, during the meeting.
BIOLASE will showcase its entire line of products at the
meeting, including the WaterLase® iPlus, and, as a special
activity, will feature Cirque du Soleil performers at its Booth
#600. The Cirque du Soleil performers will appear at 11 a.m., noon,
1 p.m. and 2 p.m. daily starting Sunday.
The new generation EPIC X diode laser demonstrates the Company’s
ability to listen closely to its customers and respond to their
needs and the needs of the marketplace with high-quality, reliable,
customer-preferred products, noted President and CEO Jeffrey M.
Nugent.
“We believe the new EPIC X diode laser is a prime example of how
the three pillars of the new BIOLASE, which include customer
satisfaction, quality in everything we do and disciplined
innovation, will benefit dentists worldwide,” Nugent said. “It’s
exciting to see the transformation that is going on within BIOLASE
and we invite you to stop by our booth and see for yourself. It’s a
new day at BIOLASE so please join us.”
The EPIC X, the newest generation of the Company’s award-winning
EPIC diode lasers for dentists and hygienists, features new
software technology and a new cordless foot pedal, among other
notable innovations. The EPIC X offers fast access, fast whitening
and hygiene versatility along with its features such as exclusive
Pain Therapy treatment modes, simplified user controls and enhanced
ComfortPulse™ settings to deliver greater patient comfort. The EPIC
X was created to be the most versatile, most responsive and most
portable diode laser on the market so dentists can delight their
patients, faster.
Along with the Cirque du Soleil performers, the Company will
also host a variety of promotions and activities at its Booth
#600.
A series of live patient courses and lectures will also be held
including:
- “The Total Technology Solution: Take
Your Practice to the Cutting Edge,’ presented by Howard Golan, DDS,
from 9 a.m.-Noon, and 2-5 p.m. on Sunday, Nov. 30
- “Using Dental Lasers in Today’s World,”
a lecture presented by Samuel Low, DDS, from 9 a.m.-noon on Monday,
Dec. 1
- “Utilizing Laser Technology in a
Periodontal Environment,” a laser hands-on course presented by
Samuel Low, DDS, from 2-5 p.m. on Monday, Dec. 1.
For more information, visit Booth #600 or call 888-4-BIOLASE
(888-424-6527).
About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical device company that develops,
manufactures, and markets innovative lasers in dentistry and
medicine and also markets and distributes high-end 2D and 3D
digital imaging equipment, CAD/CAM
intraoral scanners, and in-office milling machines and 3D printers.
BIOLASE’s products are focused on technologies that advance the
practice of dentistry and medicine and offer
benefits and value to healthcare professionals and their
patients. The Company's proprietary laser products
incorporate approximately 300 patented and patent-pending
technologies designed to provide biologically clinically superior
performance with less pain and faster recovery times. Its
innovative products provide cutting-edge technology at competitive
prices to deliver the best results for dentists and patients.
BIOLASE's principal products are revolutionary dental laser systems
that perform a broad range of dental procedures, including cosmetic
and complex surgical applications, and a full line of dental
imaging equipment. BIOLASE has sold more than 26,000 laser systems.
Laser products under development address the Company’s core dental
market and other adjacent medical and consumer markets.
For updates and information on WaterLase and laser dentistry,
find BIOLASE online at www.biolase.com, Facebook at
www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc,
Pinterest at www.pinterest.com/biolase, LinkedIn at
www.linkedin.com/company/biolase, Google+ at
www.google.com/+BIOLASEIrvine, Instagram at
www.instagram.com/biolaseinc, and
YouTube at www.youtube.com/biolasevideos.
BIOLASE® and WaterLase® are registered trademarks of BIOLASE,
Inc.
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995
Statements contained in this press release that refer to
BIOLASE's estimated or anticipated future results or other
non-historical facts are forward-looking statements, as are any
statements in this press release concerning prospects related to
BIOLASE's strategic initiatives and anticipated financial
performance. Forward-looking statements can also be identified
through the use of words such as “anticipates,” “expects,”
“intends,” “plans,” “believes,” “seeks,” “estimates,” “may,”
“will,” and variations of these words or similar expressions.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which reflect BIOLASE's current
perspective of existing trends and information and speak only as of
the date of this release. Actual results may differ materially from
BIOLASE’s current expectations depending upon a number of factors
affecting BIOLASE’s business. These factors include, among others,
adverse changes in general economic and market conditions,
competitive factors including but not limited to pricing pressures
and new product introductions, uncertainty of customer acceptance
of new product offerings and market changes, risks associated with
managing the growth of the business, and those other risks and
uncertainties that may be detailed, from time-to-time, in BIOLASE's
reports filed with the SEC. BIOLASE does not undertake any
responsibility to revise or update any forward-looking statements
contained herein.
Allen & Caron(Investors) Rene
Caron949-474-4300rene@allencaron.comor(Media) Len
Hall949.474.4300Len@allencaron.com
Biolase (NASDAQ:BIOL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biolase (NASDAQ:BIOL)
Historical Stock Chart
From Apr 2023 to Apr 2024